Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aldosterone, the Mineralocorticoid Receptor, and Cardiovascular Disease in Obesity
NCT04519164Phase 4Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Dec 2020
- Primary completion
- Sep 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of eplerenone in cardiovascular disease (CVD), sponsored by Brigham and Women's Hospital. Started Dec 2020; status: completed.
02
Drugs
eplerenone
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT04519164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04519164.